Matches in Wikidata for { <http://www.wikidata.org/entity/Q64045175> ?p ?o ?g. }
Showing items 1 to 85 of
85
with 100 items per page.
- Q64045175 description "clinical trial" @default.
- Q64045175 description "ensayu clínicu" @default.
- Q64045175 description "klinisch onderzoek" @default.
- Q64045175 description "клінічне випробування" @default.
- Q64045175 description "կլինիկական փորձարկում" @default.
- Q64045175 name "Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder" @default.
- Q64045175 type Item @default.
- Q64045175 label "Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder" @default.
- Q64045175 prefLabel "Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder" @default.
- Q64045175 P1132 Q64045175-ED1C13B8-4F9F-4452-AC6F-EAFBE9FAD241 @default.
- Q64045175 P1476 Q64045175-4D03F615-AC53-4BAB-84B1-C93BE6589657 @default.
- Q64045175 P17 Q64045175-20E288D4-7ABD-4ED8-99A5-E6147D2CE9D0 @default.
- Q64045175 P17 Q64045175-21B1021A-038A-41DA-BF5B-F710F64967C0 @default.
- Q64045175 P17 Q64045175-45151614-3467-485C-95BC-23FACA5E4E96 @default.
- Q64045175 P17 Q64045175-4F660B59-4C2B-42BF-96FD-48C981A72374 @default.
- Q64045175 P17 Q64045175-5132B52B-74CA-42DE-B315-9FC50BFDDBBB @default.
- Q64045175 P17 Q64045175-5503ECE6-3304-44A0-A26E-BEE7067FB273 @default.
- Q64045175 P17 Q64045175-57AAEB8F-9423-4654-9744-0A7A85E02C17 @default.
- Q64045175 P17 Q64045175-586A5081-934D-440F-80C0-A78DE54134C9 @default.
- Q64045175 P17 Q64045175-5A889F4A-140B-4022-8866-7B985994E59F @default.
- Q64045175 P17 Q64045175-5F2C4582-CFA3-4B4F-9998-78C4FD27AB25 @default.
- Q64045175 P17 Q64045175-6695AF9F-DB15-4AA2-A683-F27C86F2C172 @default.
- Q64045175 P17 Q64045175-6DCD1AB3-1574-4A2B-B351-8F1293560A65 @default.
- Q64045175 P17 Q64045175-6E43783D-9696-4BE7-B6AD-8191367552BF @default.
- Q64045175 P17 Q64045175-7A941D84-B49D-4CC8-A882-59EBDB202E11 @default.
- Q64045175 P17 Q64045175-86D72F57-38DF-47AB-9DCA-AECCC4880C52 @default.
- Q64045175 P17 Q64045175-8F452F9F-ABC9-409F-B5E4-9E78FA591FC4 @default.
- Q64045175 P17 Q64045175-916F619B-6F21-4DB3-8B12-10104A6A1DAC @default.
- Q64045175 P17 Q64045175-B9CC92C0-EFF6-4519-BBEB-3D972F38D21A @default.
- Q64045175 P17 Q64045175-C289A52B-D537-43F5-A0AF-07EBAA8D3D67 @default.
- Q64045175 P17 Q64045175-CB5C87FD-4123-462F-B8B2-7580AE14BA14 @default.
- Q64045175 P17 Q64045175-CBC89117-B4C6-4244-8219-543E77E9F096 @default.
- Q64045175 P17 Q64045175-CC930CD4-0A39-4D2F-8E7B-4ADF108DB7EE @default.
- Q64045175 P17 Q64045175-D0AB993C-560D-4799-ABE6-00F072813172 @default.
- Q64045175 P17 Q64045175-D7CEDDC1-AA6C-4353-BBBB-A50F27EFA696 @default.
- Q64045175 P17 Q64045175-D8D2E6A0-B287-433B-A9F8-43777118E12B @default.
- Q64045175 P17 Q64045175-F241DF3F-67D8-4D8D-BC05-44240AE7B3EE @default.
- Q64045175 P17 Q64045175-F83F6D4D-08D6-4061-8194-BB1088DEC835 @default.
- Q64045175 P17 Q64045175-FD8E0133-432F-4D4C-ABC7-0D0F4F7D439C @default.
- Q64045175 P1813 Q64045175-F4F649CD-F332-4573-87E3-DCA7CAABF5A0 @default.
- Q64045175 P2899 Q64045175-C714ECD3-26AC-42C7-9515-53504F181CCE @default.
- Q64045175 P3098 Q64045175-7D0A967A-9C61-4550-AC1E-EEB38B78BDE5 @default.
- Q64045175 P31 Q64045175-38D822E6-F427-4997-B480-9E79A1C36004 @default.
- Q64045175 P580 Q64045175-3511100A-7705-4973-95BE-00D660DCFE79 @default.
- Q64045175 P582 Q64045175-10C03A63-EB78-4C64-887F-65EBCF05126E @default.
- Q64045175 P6099 Q64045175-0363A26B-C553-414D-90ED-CD2B8E792278 @default.
- Q64045175 P8363 Q64045175-ED71E065-48D5-448E-B17E-B373828C8CE8 @default.
- Q64045175 P1132 "+2336" @default.
- Q64045175 P1476 "A Randomized, Double-Blind, Parallel Group, Placebo and Active Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder" @default.
- Q64045175 P17 Q142 @default.
- Q64045175 P17 Q145 @default.
- Q64045175 P17 Q183 @default.
- Q64045175 P17 Q184 @default.
- Q64045175 P17 Q189 @default.
- Q64045175 P17 Q20 @default.
- Q64045175 P17 Q211 @default.
- Q64045175 P17 Q212 @default.
- Q64045175 P17 Q214 @default.
- Q64045175 P17 Q218 @default.
- Q64045175 P17 Q219 @default.
- Q64045175 P17 Q258 @default.
- Q64045175 P17 Q27 @default.
- Q64045175 P17 Q28 @default.
- Q64045175 P17 Q29 @default.
- Q64045175 P17 Q31 @default.
- Q64045175 P17 Q33 @default.
- Q64045175 P17 Q34 @default.
- Q64045175 P17 Q35 @default.
- Q64045175 P17 Q36 @default.
- Q64045175 P17 Q37 @default.
- Q64045175 P17 Q38 @default.
- Q64045175 P17 Q39 @default.
- Q64045175 P17 Q40 @default.
- Q64045175 P17 Q408 @default.
- Q64045175 P17 Q41 @default.
- Q64045175 P17 Q45 @default.
- Q64045175 P17 Q55 @default.
- Q64045175 P1813 "SCORPIO" @default.
- Q64045175 P2899 "+18" @default.
- Q64045175 P3098 "NCT00689104" @default.
- Q64045175 P31 Q30612 @default.
- Q64045175 P580 "2008-04-28T00:00:00Z" @default.
- Q64045175 P582 "2009-03-24T00:00:00Z" @default.
- Q64045175 P6099 Q42824827 @default.
- Q64045175 P8363 Q78089383 @default.